Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Vaccines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2017

A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice

Foote, J. B., Kok, M., Leatherman, J. M., Armstrong, T. D., Marcinkowski, B. C., Ojalvo, L. S., Kanne, D. B., Jaffee, E. M., Dubensky, T. W. & Emens, L. A. Jun 1 2017 In : Cancer Immunology Research. 5, 6, p. 468-479 12 p.

Research output: Research - peer-reviewArticle

OX40 Receptor
Interferons
Immunity
T-Lymphocytes
Growth

Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape

Emens, L. A., Ascierto, P. A., Darcy, P. K., Demaria, S., Eggermont, A. M. M., Redmond, W. L., Seliger, B. & Marincola, F. M. Aug 1 2017 In : European Journal of Cancer. 81, p. 116-129 14 p.

Research output: Research - peer-reviewReview article

Immunotherapy
Neoplasms
Therapeutics
Biomarkers
Survival

Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo

Sunay, M. M. E., Foote, J. B., Leatherman, J. M., Edwards, J. P., Armstrong, T. D., Nirschl, C. J., Hicks, J. & Emens, L. A. May 1 2017 In : International Immunopharmacology. 46, p. 112-123 12 p.

Research output: Research - peer-reviewArticle

Immunity
Vaccination
T-Lymphocytes
Neoplasms
sorafenib

Cancer immunotherapy trials: Leading a paradigm shift in drug development

Emens, L. A., Butterfield, L. H., Hodi, F. S., Marincola, F. M. & Kaufman, H. L. Jul 19 2016 In : Journal for ImmunoTherapy of Cancer. 4, 1, 42

Research output: Research - peer-reviewComment/debate

It's TIME for a biomarker-driven approach to cancer immunotherapy

Emens, L. A. Aug 16 2016 In : Journal for ImmunoTherapy of Cancer. 4, 1, 43

Research output: Research - peer-reviewComment/debate